DENTSPLY SIRONA Inc (NASDAQ:XRAY) Shares Sold by Clean Yield Group

Clean Yield Group trimmed its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 2.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 108,035 shares of the medical instruments supplier’s stock after selling 3,225 shares during the quarter. DENTSPLY SIRONA makes up about 1.9% of Clean Yield Group’s investment portfolio, making the stock its 8th largest holding. Clean Yield Group’s holdings in DENTSPLY SIRONA were worth $5,759,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Wetherby Asset Management Inc. increased its position in DENTSPLY SIRONA by 4.5% in the 2nd quarter. Wetherby Asset Management Inc. now owns 4,663 shares of the medical instruments supplier’s stock worth $272,000 after buying an additional 201 shares during the period. Diversified Trust Co increased its position in DENTSPLY SIRONA by 3.0% in the 2nd quarter. Diversified Trust Co now owns 7,077 shares of the medical instruments supplier’s stock worth $413,000 after buying an additional 205 shares during the period. Osborne Partners Capital Management LLC increased its position in DENTSPLY SIRONA by 0.3% in the 2nd quarter. Osborne Partners Capital Management LLC now owns 68,720 shares of the medical instruments supplier’s stock worth $4,011,000 after buying an additional 205 shares during the period. Municipal Employees Retirement System of Michigan increased its position in DENTSPLY SIRONA by 8.4% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 3,240 shares of the medical instruments supplier’s stock worth $189,000 after buying an additional 250 shares during the period. Finally, Commerce Bank increased its position in DENTSPLY SIRONA by 1.9% in the 2nd quarter. Commerce Bank now owns 13,924 shares of the medical instruments supplier’s stock worth $813,000 after buying an additional 263 shares during the period. Institutional investors and hedge funds own 94.72% of the company’s stock.

Shares of NASDAQ:XRAY traded down $1.35 during trading on Thursday, hitting $53.05. 28,839 shares of the stock were exchanged, compared to its average volume of 1,410,909. DENTSPLY SIRONA Inc has a 1-year low of $33.93 and a 1-year high of $59.40. The company has a market capitalization of $12.20 billion, a price-to-earnings ratio of 26.37, a price-to-earnings-growth ratio of 1.96 and a beta of 0.98. The company’s fifty day simple moving average is $52.70 and its 200-day simple moving average is $53.83. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, August 2nd. The medical instruments supplier reported $0.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.04. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.04 billion. During the same quarter last year, the firm earned $0.60 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 3.1% compared to the same quarter last year. On average, research analysts forecast that DENTSPLY SIRONA Inc will post 2.39 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were paid a $0.10 dividend. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Thursday, September 26th. This represents a $0.40 annualized dividend and a yield of 0.75%. DENTSPLY SIRONA’s payout ratio is currently 19.90%.

Several brokerages have commented on XRAY. Wellington Shields raised DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research report on Friday, August 2nd. Evercore ISI began coverage on DENTSPLY SIRONA in a research report on Friday, July 26th. They issued an “in-line” rating on the stock. ValuEngine downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Barrington Research reaffirmed a “buy” rating and issued a $63.00 price target on shares of DENTSPLY SIRONA in a research report on Monday, August 5th. Finally, BidaskClub raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $55.75.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: What is meant by a buy rating?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.